대한물리의학회지 (Journal of the Korean Society of Physical Medicine)

  • 제18권4호
  • /
  • Pages.57-66
  • /
  • 2023
  • /
  • 1975-311X(pISSN)
  • /
  • 2287-7215(eISSN)
대한물리의학회 (The Korean Society of Physical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Comprehensive Cross-sectional Study of Sarcopenia in Young Korean Women: Assessing Body Dimensions, Clinical Indicators, and Behavioral Traits for Hazardous Components and Proportional Analysis

  • 투고 : 2023.11.08
  • 심사 : 2023.11.15
  • 발행 : 2023.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

PURPOSE: This research investigated clinical hazardous components and analyzed the proportion of sarcopenia among young Korean women. METHODS: The cross-sectional study included 1,236 women aged 20 to 29 years, categorized into two groups according to their skeletal muscle mass index (SMI). Of these, 20 participants were placed in the sarcopenia group, while 1,216 were included in the normal group. The analysis involved hazardous components including body dimensions, clinical indicators, and behavioral trait variables: height, weight, body mass index, waist circumference, skeletal muscle mass index, systolic and diastolic blood pressure, blood laboratory tests assessing fasting glucose, triglycerides, total cholesterol, as well as smoking habits and alcohol consumption. Complex sampling analysis was used to analyze the proportion and hazardous components of sarcopenia. RESULTS: The proportion of sarcopenia was at 1.76% (95% of CI: 1.08-2.83). Anthropometric measurements, such as height, BMI, and WC, exhibited significant differences between the groups (p < .05). However, there was no significant difference in weight (p > .05) between the two groups. Among the clinical indicators, SBP, DBP, FBG, serum triglycerides, and total TC found to be significant hazardous components for sarcopenia within both groups (p < .05). Smoking status as a behavioral trait was significant as well (p < .05), unlike alcohol consumption (p > .05). CONCLUSION: This study discerned both the proportion of sarcopenia and the hazardous components associated with it among community-dwelling women of a young age.

키워드

참고문헌

  1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-1S. https://doi.org/10.1093/jn/127.5.990S
  2. Critchley MJTL. The neurology of old age. 1931;217(5621):1119-27. https://doi.org/10.1016/S0140-6736(00)90705-0
  3. Kulik CT, Ryan S, Harper S, et al. Aging populations and management. Academy of Management Briarcliff Manor, NY. 2014. 929-35.
  4. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69(5):584-90. https://doi.org/10.1093/gerona/glu013
  5. Htun NC, Ishikawa-Takata K, Kuroda A, et al. Screening for malnutrition in community-dwelling older Japanese: preliminary development and evaluation of the Japanese nutritional risk screening tool (NRST). J Nutr Health Aging. 2016;20(2):114-20. https://doi.org/10.1007/s12603-015-0555-3
  6. Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea national health and nutrition examination surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902.
  7. Cawthon PM, Blackwell TL, Cauley J, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc. 2015;63(11):2247-59. https://doi.org/10.1111/jgs.13788
  8. Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59(1):59-65. https://doi.org/10.1590/2359-3997000000011
  9. Laurent MR, Dedeyne L, Dupont J, et al. Age-related bone loss and sarcopenia in men. Maturitas. 2019;122:51-6. https://doi.org/10.1016/j.maturitas.2019.01.006
  10. Reijnierse EM, de van der Schueren MAE, Trappenburg MC, et al. Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS One. 2017;12(10):e0185837.
  11. Mehiret G, Molla A, Tesfaw A. Knowledge on risk factors and practice of early detection methods of breast cancer among graduating students of Debre Tabor University, Northcentral Ethiopia. BMC Womens Health. 2022;22(1):183.
  12. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. Int J Environ Res Public Health. 2022;19(12):7232.
  13. Hwang J, Park S. Sex differences of sarcopenia in an elderly asian population: the prevalence and risk factors. Int J Environ Res Public Health. 2022;19(19): 11980.
  14. Hwang J. Unraveling the contributing factors of sarcopenia in young Korean male adults: a study of occurrence, somatometric, biochemical, and behavioral characteristics. J Korean Soc Phys Med. 2023;18(3): 21-30. https://doi.org/10.13066/kspm.2023.18.3.21
  15. Hwang J. Comprehensive investigation on the prevalence and risk factors of coexistence of age-related loss of skeletal muscle mass and obesity among males in their 40s. J Korean Soc Phys Med. 2023;18(3):1-9. https://doi.org/10.13066/kspm.2023.18.3.1
  16. Hwang J. Age-related loss of skeletal muscle and associated risk factors in middle-aged men: a comprehensive study. J Korean Soc Phys Med. 2023;18(2):13-21. https://doi.org/10.13066/kspm.2023.18.2.13
  17. Hwang J. Prevalence, anthropometric risk factors, and clinical risk factors in sarcopenic women in their 40s. J Korean Soc Phys Med. 2023;18(2):23-31. https://doi.org/10.3346/jkms.2003.18.1.23
  18. Hwang J, Moon IY. Exploring incidence and potential risk factors of sarcopenic obesity among middle-aged women residing in a community. J Korean Soc Phys Med. 2023;18(3):11-9. https://doi.org/10.13066/kspm.2023.18.3.11
  19. Hwang J, Park S. Gender-specific prevalence and risk factors of sarcopenic obesity in the korean elderly population: a nationwide cross-sectional study. Int J Environ Res Public Health. 2023;20(2):1140.
  20. Hwang J, Park S. A Korean nationwide cross-sectional study investigating risk factors, prevalence, and characteristics of sarcopenia in men in early old age. Healthcare. MDPI. 2023. 2860.
  21. Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2-3):211-22. https://doi.org/10.1016/0022-510X(86)90009-2
  22. Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66(4):904-10. https://doi.org/10.1093/ajcn/66.4.904
  23. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8. https://doi.org/10.1152/jappl.2000.89.1.81
  24. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. https://doi.org/10.1046/j.1532-5415.2002.50216.x
  25. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
  26. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65. https://doi.org/10.1007/s00421-010-1473-z
  27. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8. https://doi.org/10.1002/jcsm.12073
  28. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa Ageing study. Revista De Nutricao-Brazilian Journal of Nutrition. 2017;30(3):287-96. https://doi.org/10.1590/1678-98652017000300002
  29. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95. https://doi.org/10.1016/j.numecd.2007.10.002
  30. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63. https://doi.org/10.1093/ajcn/81.5.953
  31. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr. 2005;82(2):428-34. https://doi.org/10.1093/ajcn/82.2.428
  32. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7. https://doi.org/10.1016/j.orcp.2012.02.003
  33. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60. https://doi.org/10.1111/jgs.12652
  34. Androga L, Sharma D, Amodu A, et al. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int Rep. 2017;2(2):201-11. https://doi.org/10.1016/j.ekir.2016.10.008
  35. Goswami B, Reang T, Sarkar S, et al. Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study. J Family Med Prim Care. 2020;9(6):2885-90. https://doi.org/10.4103/jfmpc.jfmpc_187_20
  36. Abidin Ozturk ZA, Turkbeyler IH, Demir Z, et al. The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turk J Phys Med Rehabil. 2018;64(1):72-9.  https://doi.org/10.5606/tftrd.2018.1068
  37. Du Y, Oh C, No J. Associations between sarcopenia and metabolic risk factors: a systematic review and meta-analysis. J Obes Metab Syndr. 2018;27(3):175-85. https://doi.org/10.7570/jomes.2018.27.3.175
  38. Cui M, Gang X, Wang G, et al. A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes. Medicine (Baltimore). 2020;99(2):e18708.
  39. Buscemi C, Ferro Y, Pujia R, et al. Sarcopenia and appendicular muscle mass as predictors of impaired fasting glucose/type 2 diabetes in elderly women. Nutrients. 2021;13(6):1909.
  40. Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne). 2014;5:195.
  41. Buchmann N, Nikolov J, Spira D, et al. Identifying sarcopenia in metabolic syndrome: data from the berlin aging study II. J Gerontol A Biol Sci Med Sci. 2016;71(2):265-72. https://doi.org/10.1093/gerona/glv089
  42. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109.
  43. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81. https://doi.org/10.1530/JOE-15-0533
  44. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25. https://doi.org/10.1152/japplphysiol.00627.2006
  45. Petersen AM, Magkos F, Atherton P, et al. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab. 2007;293(3):E843-8. https://doi.org/10.1152/ajpendo.00301.2007
  46. de Oca MM, Loeb E, Torres SH, et al. Peripheral muscle alterations in non-COPD smokers. Chest. 2008;133(1):13-8.  https://doi.org/10.1378/chest.07-1592